Insider · CIK 0001883804
Chee Conley
Reports to the SEC for 1 company · CAMBRIDGE, MA
Transactions
26
Companies
1
Filings
9
CIK
0001883804
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-11-18 | Syros Pharmaceuticals, Inc.S Sale | −$26.9K |
| 2024-10-31 | Syros Pharmaceuticals, Inc.F Tax Payment | −$18.2K |
| 2024-10-31 | Syros Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2024-10-31 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-09-11 | Syros Pharmaceuticals, Inc.P Purchase | +$85.4K |
| 2024-09-10 | Syros Pharmaceuticals, Inc.P Purchase | +$75.3K |
| 2024-04-01 | Syros Pharmaceuticals, Inc.F Tax Payment | −$17.9K |
| 2024-03-31 | Syros Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2024-03-31 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-03-31 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-03-31 | Syros Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2023-12-02 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award | — |
| 2023-11-01 | Syros Pharmaceuticals, Inc.F Tax Payment | −$13.3K |
| 2023-10-31 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-10-31 | Syros Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2023-04-03 | Syros Pharmaceuticals, Inc.F Tax Payment | −$1,697.64 |
| 2023-03-31 | Syros Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2023-03-31 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-02-16 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award | — |
| 2022-10-06 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award | — |
| 2022-10-06 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award | — |
| 2022-10-06 | Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2022-10-06 | Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2022-02-15 | Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award | — |
| 2022-02-15 | Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2021-09-27 | Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
Recent filings
- 4Chee Conley0000950170-24-129380SEC(opens sec.gov)
- 4Chee Conley0000950170-24-120866SEC(opens sec.gov)
- 4Chee Conley0000950170-24-105994SEC(opens sec.gov)
- 4Chee Conley0000950170-24-040282SEC(opens sec.gov)
- 4Chee Conley0000950170-23-068288SEC(opens sec.gov)
- 4Chee Conley0001209191-23-054167SEC(opens sec.gov)
- 4Chee Conley0001209191-23-022976SEC(opens sec.gov)
- 4Chee Conley0001209191-23-011157SEC(opens sec.gov)
- 4/AChee Conley0001209191-22-053348SEC(opens sec.gov)
Companies
Address
C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE
CAMBRIDGE, MA, 02140